alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
- Skip to main content
- About Us
- Contact Us
- FAQs
-  Language Assistance ****   - English
  - español
  - 中文: 繁體版
  - Việt-ngữ
  - 한국어
  - Tagalog
  - Русский

U.S. Department of Education

U.S. Department of Education

            - Student Loans
            - Grants
            - Laws
            - Data

|                                            |
|--------------------------------------------|
|                                            | PurposeFunding StatusEligibilityLaws, Regs, & GuidanceApplicant InfoResourcesAwardsFAQsPerformanceContacts |  |
| Office of Communications and Outreach Home |
|                                            |

## How to Apply

 

Each state is invited to submit up to five  pre-K–12 school or district nominations annually, and one college or university  nomination, for a maximum of six nominations in total. *Schools, districts,  postsecondary institutions, and early learning centers do not apply to ED for  this award, but instead apply to their state education authorities*.

  State participation in the award is voluntary  and not all state education authorities choose to nominate.  Interested candidates should contact their state  education agency or higher  education authorities to request  nomination. 

## Timeline

States generally submit their nominees to ED  by February 1, annually. They set their own state-specific application  deadlines to allow them time to review, select, and submit nominees to ED. The  U.S. Secretary of Education announces national honorees on Earth Day, April 22 and honors them at a ceremony in Washington, DC in the summer or fall.States are encouraged to offer additional state recognition titles and events,  and to partner with the private sector to offer cash prizes, amplifying the  impact of their award implementation.

----

 

 Printable view

## How Do I Find...

          - Student loans, forgiveness
          - Higher Education Rulemaking
          - College accreditation
          - Every Student Succeeds Act (ESSA)
          - FERPA
          - FAFSA
          - 1098, tax forms

More >

## Information About...

          - Elevating Teaching
          - Early Learning
          - Engage Every Student
          - Unlocking Career Success
          - Cybersecurity

 

----

*Our mission*

Student Loans
Repaying LoansDefaulted LoansLoan ForgivenessLoan Servicers

Grants & Programs
Apply for Pell GrantsGrants ForecastApply for a Grant

Laws & Guidance
Every Student Succeeds Act (ESSA)FERPACivil RightsNew IDEA Website

Data & Research
Education StatisticsPostsecondary Education DataED Data ExpressNation's Report CardWhat Works ClearinghouseOpen Data PlatformCOVID Relief Data

About Us
Contact UsED OfficesJobsPress ReleasesFAQsRecursos en españolBudget, PerformancePrivacy Program

----

          - Notices
          - FOIA
          - Privacy Policy
          - Accessibility
          - Security
          - Information quality
          - Inspector General
          - Whitehouse.gov
          - USA.gov
          - Benefits.gov
          - Regulations.gov
          - vote.gov
250.100 Definitions. *Secretarial level,* as used in this subpart, means— ( 1 ) An official at or above the level of an Assistant Secretary (or Deputy) of Defense or of the Army, Navy, or Air Force; and
( 2 ) A contract adjustment board established by the Secretary concerned.
#### The People of the State of New York ex rel. Robert Bregman v. Warden of the New York City Prison.

Motion for an enlargement of time granted insofar as to extend the appellant’s time to serve and file the record on appeal and appellant’s points to and including June 12, 1962, with notice of argument for June 21,1962, said appeal to be argued or submitted when reached. Respondent’s points are to be served and filed on or before June 18, 1962. The order of this court entered on May 4, 1962 is modified accordingly. Concur — Rabin, J. P., Valente, McNally, Stevens and Eager, JJ.
# C_2018464EN.01000401.xml

| 27.12.2018 | EN | Official Journal of the European Union | C 464/4 |
| --- | --- | --- | --- |

27.12.2018

EN

Official Journal of the European Union

C 464/4

---

Euro exchange rates (1)

21 December 2018

(2018/C 464/04)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1414 |
| JPY | Japanese yen | 126,98 |
| DKK | Danish krone | 7,4670 |
| GBP | Pound sterling | 0,90215 |
| SEK | Swedish krona | 10,2733 |
| CHF | Swiss franc | 1,1312 |
| ISK | Iceland króna | 134,10 |
| NOK | Norwegian krone | 9,9428 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 25,855 |
| HUF | Hungarian forint | 321,97 |
| PLN | Polish zloty | 4,2851 |
| RON | Romanian leu | 4,6389 |
| TRY | Turkish lira | 6,0546 |
| AUD | Australian dollar | 1,6081 |
| CAD | Canadian dollar | 1,5459 |
| HKD | Hong Kong dollar | 8,9368 |
| NZD | New Zealand dollar | 1,6925 |
| SGD | Singapore dollar | 1,5641 |
| KRW | South Korean won | 1 282,71 |
| ZAR | South African rand | 16,4753 |
| CNY | Chinese yuan renminbi | 7,8825 |
| HRK | Croatian kuna | 7,4216 |
| IDR | Indonesian rupiah | 16 696,34 |
| MYR | Malaysian ringgit | 4,7608 |
| PHP | Philippine peso | 60,546 |
| RUB | Russian rouble | 78,2103 |
| THB | Thai baht | 37,267 |
| BRL | Brazilian real | 4,4099 |
| MXN | Mexican peso | 22,7547 |
| INR | Indian rupee | 80,0400 |

Currency

Exchange rate

USD

US dollar

1,1414

JPY

Japanese yen

126,98

DKK

Danish krone

7,4670

GBP

Pound sterling

0,90215

SEK

Swedish krona

10,2733

CHF

Swiss franc

1,1312

ISK

Iceland króna

134,10

NOK

Norwegian krone

9,9428

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,855

HUF

Hungarian forint

321,97

PLN

Polish zloty

4,2851

RON

Romanian leu

4,6389

TRY

Turkish lira

6,0546

AUD

Australian dollar

1,6081

CAD

Canadian dollar

1,5459

HKD

Hong Kong dollar

8,9368

NZD

New Zealand dollar

1,6925

SGD

Singapore dollar

1,5641

KRW

South Korean won

1 282,71

ZAR

South African rand

16,4753

CNY

Chinese yuan renminbi

7,8825

HRK

Croatian kuna

7,4216

IDR

Indonesian rupiah

16 696,34

MYR

Malaysian ringgit

4,7608

PHP

Philippine peso

60,546

RUB

Russian rouble

78,2103

THB

Thai baht

37,267

BRL

Brazilian real

4,4099

MXN

Mexican peso

22,7547

INR

Indian rupee

80,0400

---

(1)  Source: reference exchange rate published by the ECB.

---
# C_2019181EN.01000101.xml

| 27.5.2019 | EN | Official Journal of the European Union | C 181/1 |
| --- | --- | --- | --- |

27.5.2019

EN

Official Journal of the European Union

C 181/1

---

Euro exchange rates (1)

24 May 2019

(2019/C 181/01)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1187 |
| JPY | Japanese yen | 122,61 |
| DKK | Danish krone | 7,4678 |
| GBP | Pound sterling | 0,88318 |
| SEK | Swedish krona | 10,7098 |
| CHF | Swiss franc | 1,1215 |
| ISK | Iceland króna | 138,30 |
| NOK | Norwegian krone | 9,7558 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 25,830 |
| HUF | Hungarian forint | 325,95 |
| PLN | Polish zloty | 4,2974 |
| RON | Romanian leu | 4,7619 |
| TRY | Turkish lira | 6,7988 |
| AUD | Australian dollar | 1,6205 |
| CAD | Canadian dollar | 1,5053 |
| HKD | Hong Kong dollar | 8,7806 |
| NZD | New Zealand dollar | 1,7109 |
| SGD | Singapore dollar | 1,5403 |
| KRW | South Korean won | 1 328,29 |
| ZAR | South African rand | 16,1554 |
| CNY | Chinese yuan renminbi | 7,7206 |
| HRK | Croatian kuna | 7,4258 |
| IDR | Indonesian rupiah | 16 100,89 |
| MYR | Malaysian ringgit | 4,6857 |
| PHP | Philippine peso | 58,403 |
| RUB | Russian rouble | 72,1352 |
| THB | Thai baht | 35,636 |
| BRL | Brazilian real | 4,5247 |
| MXN | Mexican peso | 21,3057 |
| INR | Indian rupee | 77,8000 |

Currency

Exchange rate

USD

US dollar

1,1187

JPY

Japanese yen

122,61

DKK

Danish krone

7,4678

GBP

Pound sterling

0,88318

SEK

Swedish krona

10,7098

CHF

Swiss franc

1,1215

ISK

Iceland króna

138,30

NOK

Norwegian krone

9,7558

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,830

HUF

Hungarian forint

325,95

PLN

Polish zloty

4,2974

RON

Romanian leu

4,7619

TRY

Turkish lira

6,7988

AUD

Australian dollar

1,6205

CAD

Canadian dollar

1,5053

HKD

Hong Kong dollar

8,7806

NZD

New Zealand dollar

1,7109

SGD

Singapore dollar

1,5403

KRW

South Korean won

1 328,29

ZAR

South African rand

16,1554

CNY

Chinese yuan renminbi

7,7206

HRK

Croatian kuna

7,4258

IDR

Indonesian rupiah

16 100,89

MYR

Malaysian ringgit

4,6857

PHP

Philippine peso

58,403

RUB

Russian rouble

72,1352

THB

Thai baht

35,636

BRL

Brazilian real

4,5247

MXN

Mexican peso

21,3057

INR

Indian rupee

77,8000

---

(1)  Source: reference exchange rate published by the ECB.

---
**Exhibit 23.1**

 

**Consent of Independent Registered Public Accounting Firm**

 

We consent to theincorporation by reference in the Registration Statements (Form S-8 Nos.333-64316, 333-83723, 333-59667 and 333-33095) of our report dated March 28,2006, with respect to the consolidated financial statements of NationalMercantile Bancorp and subsidiaries included in the Annual Report (Form 10-KSB)for the year ended December 31, 2005.

 
|   | /s/ Moss Adams LLP |   |
|--------|--------------------|--------|

 

Los Angeles, California

March 31, 2006

 

1

----
| 1. | I      have reviewed this annual report on Form 10-K of Farmers Capital Bank      Corporation; |
|----|------------------------------------------------------------------------------------------------|

| 2. | Based      on my knowledge, this report does not contain any untrue statement of a      material fact or omit to state a material fact necessary to make the      statements made, in light of the circumstances under which such statements      were made, not misleading with respect to the period covered by this      report; |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | Based      on my knowledge, the financial statements, and other financial information      included in this report, fairly present in all material respects the      financial condition, results of operations and cash flows of the      registrant as of, and for, the periods presented in this      report; |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4. | The      registrant's other certifying officer and I are responsible for      establishing and maintaining disclosure controls and procedures (as      defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal      control over financial reporting (as defined in Exchange Act Rules      13a-15(f) and 15d-15(f)) for the registrant and  have: |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5. | The      registrant's other certifying officer and I have disclosed, based on our      most recent evaluation of internal control over financial reporting, to      the registrant's auditors and the audit committee of the registrant's      board of directors (or persons performing the equivalent      functions): |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:  |        March 11, 2009 |   | /s/      G. Anthony Busseni  |   |
|--------|----------------------------|--------|-----------------------------------|--------|
|   |                       |   | G.      Anthony Busseni           |   |
|   |                       |   | President      and CEO            |   |

----
<TABLE> <S> <C>

<ARTICLE> 5
<RESTATED>
<CIK> 0000714560
<NAME> US AIRWAYS, INC.
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                         950,134
<SECURITIES>                                   635,839
<RECEIVABLES>                                  325,478<F1><F3>
<ALLOWANCES>                                         0<F1>
<INVENTORY>                                    211,184
<CURRENT-ASSETS>                             2,252,015<F3>
<PP&E>                                       6,137,671
<DEPRECIATION>                               2,381,844
<TOTAL-ASSETS>                               7,392,533<F3>
<CURRENT-LIABILITIES>                        2,671,399<F3>
<BONDS>                                      2,614,818
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             1
<OTHER-SE>                                    (85,155)
<TOTAL-LIABILITY-AND-EQUITY>                 7,392,533<F3>
<SALES>                                              0
<TOTAL-REVENUES>                             7,704,057
<CGS>                                                0
<TOTAL-COSTS>                                7,335,389
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             283,936
<INCOME-PRETAX>                                191,043
<INCOME-TAX>                                     7,811
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   183,232
<EPS-PRIMARY>                                        0<F2>
<EPS-DILUTED>                                        0<F2>
<FN>
<F1>Receivables are presented net of allowances.
<F2>EPS calculations are not relevant because US Airways, Inc. is a wholly-owned
subsidiary of US Airways Group, Inc.
<F3>This amount was restated to conform with current classifications.
</FN>
        

</TABLE>
xml version="1.0" encoding="UTF-8"?


C\_2019191EN.01014301.xml


| | | | |
| --- | --- | --- | --- |
| 6.6.2019 | EN | Official Journal of the European Union | C 191/143 |

---

NOTICE OF OPEN COMPETITION

(2019/C 191/05)

The European Personnel Selection Office (EPSO) is organising the following open competition:

| | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| | EPSO/AD/374/19 – ADMINISTRATORS (AD 7) IN THE FOLLOWING FIELDS | | | | --- | --- | | 1. | Competition Law | | | | | --- | --- | | 2. | Financial Law | | | | | --- | --- | | 3. | Economic and Monetary Union Law | | | | | --- | --- | | 4. | Financial rules applicable to the EU budget | | | | | --- | --- | | 5. | Protection of euro coins against counterfeiting | |

The competition notice is published in 24 languages in [Official Journal of the European Union C 191 A of 6 June 2019](http://publications.europa.eu/resource/oj/JOC_2019_191_A_TOC).

Further information can be found on the EPSO website: https://epso.europa.eu/

---
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

JAKE DOUGLAS BYLSMA,

Petitioner :

:

:

:

:

:

:

:

:

:

: No. 95 MAL 2024

Petition for Allowance of Appeal

from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW , this 8th day of July, 2024

, the Petition for Allowance of Appeal is

DENIED

.
IN THE SUPREME COURT OF THE STATE OF MONTANA No. DA 20
- 0 17 5 STATE OF MONTANA,

Plaintiff and Appellee, v. NATALIE AMANDA RICH ,

Defendant and Appellant
.

**ORDER** Upon consideration of Appellant’s motion for extension of time, and good cause appearing, IT IS HEREBY ORDERED that Appellant is granted an extension of time to and including February 3 , 202 1 , within which to prepare, file, and serve Appellant’s opening brief on appeal.

Electronically signed by: Mike McGrath Chief Justice, Montana Supreme Court

December 28 2020

12/28/2020

Case Number: DA 20-0175
Narrative Form of Series F Stock Certificate [FACE OF CERTIFICATE]

                         Incorporated Under The Laws of
                                     Nevada

                              BIOMUNE SYSTEMS, INC.
Number _____                                                 _________ Shares

           Series8% Cumulative Convertible Non-Voting Preferred Stock

                        SEE RESTRICTIVE LEGEND ON REVERSE

THIS CERTIFIES THAT  _____________  is the  recordholder of  ___________________
shares of Series F 8% Cumulative Convertible Non-Voting Preferred Stock, $0.0001
par value per share, of Biomune Systems, Inc., transferable only on the Books of
the Corporation by the holder hereof in person, or by duly authorized  attorney,
on the surrender of this certificate properly endorsed.

IN  WITNESS  WHEREOF  the duly  authorized  officers  of this  Corporation  have
hereunto subscribed their names and caused the Seal to be hereto affixed at Salt
Lake City, Utah this ___ day of ______________, ____ A.D.


------------------------------             -----------------------------------
                   , Secretary                                  , President


                         Shares $0.0001 EachREVERSE SIDE OF CERTIFICATE:

   For value received,  ______ hereby sell, assign and transfer  unto___________
 ______________ shares of the Capital Stock represented by the within
Certificate,  and do hereby irrevocably constitute and appoint  ________________
to transfer  the said Stock on the books of the within  named  Corporation  with
full power of substitution in the premises.


Dated:  _______________________, ____

In presence of
  -------------------------------            -------------------------------


NOTICE: THE SIGNATURES ON THIS ASSIGNMENT MUST CORRESPOND WITH THE NAMES AS
WRITTEN UPON THE FACE OF THIS CERTIFICATE, IN EVERY PARTICULAR, WITHOUT
ALTERATION OR ENLARGEMENT, OR ANY CHANGE WHATSOEVER.

THE SECURITIES  REPRESENTED BY THIS  CERTIFICATE  HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER ANY APPLICABLE STATE SECURITIES
LAWS, AND MAY NOT BE TRANSFERRED OR OTHERWISE  DISPOSED OF UNLESS THEY HAVE BEEN
REGISTERED  UNDER  THAT  ACT AND ANY  APPLICABLE  STATE  SECURITIES  LAWS OR THE
CORPORATION  RECEIVES AN OPINION OF COUNSEL SATISFACTORY TO IT THAT AN EXEMPTION
FROM REGISTRATION IS AVAILABLE.  THE SHARES MAY NOT BE OFFERED FOR SALE, SOLD OR
OTHERWISE  TRANSFERRED  EXCEPT PURSUANT TO AN EFFECTIVE  REGISTRATION  STATEMENT
UNDER THE ACT OR PURSUANT TO AN EXEMPTION FROM  REGISTRATION  UNDER THE ACT, THE
AVAILABILITY OF WHICH IS TO BE ESTABLISHED TO THE SATISFACTION OF THE COMPANY.

A FULL STATEMENT OF THE VOTING POWERS, DESIGNATIONS,  PREFERENCES,  LIMITATIONS,
RESTRICTIONS  AND  RELATIVE  RIGHTS  GRANTED TO OR IMPOSED  UPON THE  RESPECTIVE
CLASSES  AND  FOR  SERIES  OF  SHARES  OF  STOCK  OF  THE  CORPORATION  AND  THE
QUALIFICATIONS,  LIMITATIONS AND  RESTRICTIONS OF SUCH RIGHTS MAY BE OBTAINED BY
ANY SHAREHOLDER  UPON REQUEST AT THE PRINCIPAL OFFICE OF THE CORPORATION AND THE
CORPORATION  WILL  FURNISH  SUCH  SHAREHOLDER,  WITHOUT  CHARGE,  A COPY OF SUCH
STATEMENT.
Exhibit 10(n)

                               Pharmos Corporation
                         99 Wood Avenue South, Suite 301
                                Iselin, NJ 08830

Elkan R. Gamzu, Ph.D.
33 Nobscot Road
Newton, MA 02459

Re: Consulting Agreement

Dear Dr. Gamzu:

This letter  confirms the agreement of Pharmos  Corporation  (the  "Company") to
retain you as of  January  21,  2000 as a  non-exclusive  consultant  to provide
assistance and consulting  services to the company on matters generally relating
to the development of Pharmos' drug candidates, and specifically to dexanabinol.

In  consideration  for your  services,  the  Company  will pay you on a per diem
basis, as and when needed,  at the rate of $3,000 per day. In addition,  we will
request the Compensation  Committee of the Board of Directors to agree that your
upcoming grant of Director's options be issued as of the date of this agreement.

The Company agrees to reimburse you for your out-of-pocket  expenses incurred on
its behalf upon the submission of reasonably detailed statements of all fees and
expenses for which payment is requested,  with explanations,  within thirty (30)
days of  receipt  of such  requests.  All  requests  for  reimbursement  must be
submitted  within  six  months  after  the  conclusion  or  termination  of this
Agreement.

This  Agreement  will  terminate  on January 21,  2001,  subject to extension by
written agreement of the parties hereto.  Notices related to this Agreement will
be deemed to be duly given when received, if delivered by hand, or when sent, if
delivered Federal Express or other recognized  overnight courier or by certified
mail, return receipt requested.

You acknowledge  that in the course of your engagement by the Company,  you will
have  access  to  Proprietary   Information  about  the  Company's  affairs  and
prospects.  The treatment of  Proprietary  Information  shall be governed by the
Confidentiality  and  Non-Use  Agreement  between  Pharmos  and you  dated as of
November 1, 1999.

This  Agreement  and the  Confidentiality  and Non-Use  Agreement  represent the
entire agreement between the Company and you and supersede all prior agreements,
whether  written or oral.  This  agreement may only be modified by a letter duly
signed by each of the  parties  hereto and shall be  governed by the laws of the
State of New Jersey.

                                                      Very truly yours,

                                                      Pharmos Corporation

                                                      /s/ Gad Riesenfeld
                                                      ------------------
                                                      By: Gad Riesenfeld
                                                            President & COO

/s/ Elkan R. Gamzu
------------------
 Elkan R. Gamzu, Ph.D.
 33 Nobscot Road
 Newton, MA 02459
IA 

118TH CONGRESS 

2D SESSION H. J. RES. 160 

Providing for congressional disapproval under chapter 8 of title 5, United 

States Code, of the rule submitted by the Department of Health and 

Human Services relating to ‘‘Nondiscrimination in Health Programs and 

Activities’’. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 23, 2024 

Mr. ROY (for himself, Mr. LAMALFA, Mr. OGLES, Mr. DUNCAN, Mr. CRENSHAW, Mr. GOOD of Virginia, Mr. BABIN, Mr. WEBER of Texas, Mr. 

BIGGS, Mr. JACKSON of Texas, Mr. RESCHENTHALER, Mr. BRECHEEN, 

Mr. BISHOP of North Carolina, Mr. SELF, Mrs. MILLER of Illinois, Mr. 

HIGGINS of Louisiana, Mr. MORAN, and Mr. MOORE of Alabama) submitted the following joint resolution; which was referred to the Committee 

on Energy and Commerce 

JOINT RESOLUTION 

Providing for congressional disapproval under chapter 8 of 

title 5, United States Code, of the rule submitted by 

the Department of Health and Human Services relating 

to ‘‘Nondiscrimination in Health Programs and Activities’’. 

1 Resolved by the Senate and House of Representatives

2 of the United States of America in Congress assembled, 

3 That Congress disapproves the rule submitted by the De4 partment of Health and Human Services relating to 

5 ‘‘Nondiscrimination in Health Programs and Activities’’ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HJ 160 IH 

1 (89 Fed. Reg. 37522 (May 6, 2024)), and such rule shall 

2 have no force or effect. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB